Browse the Companies or do a name lookup. Theory behind the site Analysis. Contact us.

Lifecore Biomedical Inc  

Company profile

Symbol: LCBM Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology & Drugs
Market Cap: $219.49 M Data Since: 1991-01-02 Last Close : $16.91 (2008-01-18)
Website: www.lifecore.com
Links: [Web Query]    [News Query]

Analysis :    [Random Walk]   [Default Prediction]   [Fundamental Analysis]


Price Prediction

 

Random walk modeling for 2008 (what's this?). Click on the images for the high resolution version.

Initial Value* : $14.45 Historic Volatility : 3.18% Annual Drift : 7%

Predicted price distribution   Predicted high to date and low to date price

* Stock quotes on TextBiz are always adjusted close prices (what's this?).

 

Money Flow Index

 

Money FLow Index for 2008

Money Flow Index   

* To learn more about Money Flow Index (what's this?).

 

Default Prediction for 2007-06-30

 

Default prediction by Z-Score (what's this?).

Z Score :  
5.9345   

Sector         Industry
Lifecore Biomedical Inc Z score histogram (Healthcare sector)   Lifecore Biomedical Inc Z score histogram (Biotechnology & Drugs industry)

View the other companies in the same industry : Biotechnology & Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:
Z' Score :  
4.3943   

Sector         Industry
Lifecore Biomedical Inc Z' score histogram (Healthcare sector)  Lifecore Biomedical Inc Z' score histogram (Biotechnology & Drugs industry)  

For non-manufacturing companies:
Z'' Score :  
12.0812   

Sector         Industry
  Lifecore Biomedical Inc Z'' score histogram (Healthcare sector)  Lifecore Biomedical Inc Z score histogram (Biotechnology & Drugs industry)

 

Fundamental Analysis for 2007-

 

Fundamental Analysis measures (what's this?).

Date of financial statements used:  2007-12-31
Book Value : $86.509 M Internal Value : $86.509 M Working Capital : $68.847 M
Debt to Asset Ratio : 0.118 Current Ratio: 0.084 Turnover Ratio: 5.299
Net Margins : 55.652 EPS : 0.096 P/E ratio : 176.144
P/B ratio : 2.537 ROE : 0.014 ROA : 0.012